Matever

Levetiracetam, the active ingredient in Matever, is an antiepileptic presented as an injection solution for intravenous use. It is employed to control various types of seizures, including partial‑onset, myoclonic, and generalized tonic‑clonic seizures, in adult and pediatric patients as prescribed by a physician. It is approved for use in the European Union and is administered under professional medical supervision.

GNH USA supplies Matever as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, with a focus on reliable cold‑chain logistics and regulatory compliance.

Levetiracetam is used in the management of epilepsy, targeting various seizure types.

- Partial‑onset seizures: reduces frequency and severity of focal seizures. - Myoclonic seizures: controls sudden, brief muscle jerks associated with juvenile myoclonic epilepsy. - Generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of lightheadedness or unsteady balance. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate head pain. - Nausea: upset stomach with urge to vomit. - Irritability: mood changes or increased agitation. - Somnolence: excessive sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: serious skin disorder with blistering. - Blood dyscrasias: low white blood cells or platelets. - Mood disturbances: depression or suicidal thoughts. - Hepatic dysfunction: abnormal liver enzymes or hepatitis.

When using levetiracetam injection, clinicians should observe several precautions to ensure patient safety.

- Renal impairment: adjust dose or monitor renal function in patients with reduced kidney clearance. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Psychiatric history: monitor for mood changes, especially in patients with prior depression or anxiety. - Pregnancy: limited data; weigh potential benefits against unknown fetal risks. - Pediatric use: dosing must be individualized by a specialist; monitor growth and development. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control. - Phenobarbital: can lower levetiracetam concentrations, risking breakthrough seizures.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of CNS side effects such as dizziness. - Sedative antihistamines: combined use may enhance drowsiness. - Opioids: potential additive CNS depression. - Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; consider alternative contraception.